Anal Gland Cancer in Dogs: Apocrine Adenocarcinoma Treatment

Last updated: May 16, 2026

Understanding Anal Gland Cancer in Dogs

Anal gland cancer in dogs is a relatively uncommon but biologically aggressive cancer that arises from the apocrine glands located within the anal sacs. Most owners know the anal sacs only as the source of the occasional pungent expression at the groomer or vet, but these small, paired glands can develop a malignant tumor known as apocrine gland adenocarcinoma of the anal sac, often abbreviated AGASACA. Despite its small starting size, this cancer has a habit of metastasizing early to the regional sublumbar lymph nodes and beyond.

This is a cancer where early detection makes a meaningful difference in treatment options and outcomes, and where routine rectal exams during wellness visits can pick up tumors that owners cannot feel from the outside. Many cases are discovered incidentally during a wellness exam or while expressing the anal glands for unrelated reasons. For broader context on anal sac disease, see our dog anal sac cancer guide.

How AGASACA Behaves

Apocrine gland adenocarcinoma of the anal sac is locally aggressive and metastasizes early. The tumor itself can grow within the anal sac, eventually causing obvious enlargement on one side of the perianal area, but in many cases it remains small while metastasizing to the sublumbar lymph nodes (the chain of lymph nodes within the pelvic inlet). Enlarged sublumbar nodes can themselves cause clinical signs by compressing the rectum and pelvic structures, leading to constipation and tenesmus (straining to defecate).

Distant metastasis to lungs, liver, spleen, and bones can occur in advanced cases. Local invasion of perianal structures can complicate surgical removal. The challenge with AGASACA is that the regional lymph node spread is often the more important clinical problem than the primary tumor itself, which is why staging includes careful evaluation of these nodes.

Risk Factors and the Sex/Breed Picture

AGASACA was once thought to be primarily a disease of older spayed female dogs, and small-breed females do appear to be over-represented in some published case series. More recent literature has documented the disease in dogs of any sex and many breeds, including males. Cocker Spaniels, English Springer Spaniels, German Shepherds, Cavalier King Charles Spaniels, and Dachshunds are among breeds reported with notable frequency. The bottom line is that any dog of any sex and breed can develop AGASACA, and breed predisposition is a risk modifier rather than a screening tool.

Most affected dogs are middle-aged to senior. Routine rectal exams during wellness exams are the practical screening approach, particularly for senior dogs and breeds with reported predisposition. Pet insurance taken out before symptoms appear remains a strong financial-protection tool for any senior cancer diagnosis.

Paraneoplastic Hypercalcemia

This deserves a section of its own because it is one of the defining features of AGASACA and an important clue when present. A meaningful fraction of AGASACA cases produce parathyroid hormone-related protein (PTHrP), a substance that mimics parathyroid hormone and drives calcium out of bones into the bloodstream. The result is hypercalcemia of malignancy, a paraneoplastic syndrome that causes its own constellation of clinical signs even before the tumor itself becomes obvious.

Hypercalcemia signs include polyuria and polydipsia (increased drinking and urination), decreased appetite, vomiting, weakness, lethargy, and in severe cases, kidney damage from prolonged calcium derangement. A senior dog presenting with persistent hypercalcemia on routine bloodwork should always have a careful rectal exam and abdominal imaging because AGASACA is one of the leading causes of malignant hypercalcemia in dogs. Treating the hypercalcemia is part of the supportive care approach, but the only durable solution is treating the underlying cancer. Resolution of hypercalcemia after tumor removal is part of the prognostic conversation.

Recognizing the Warning Signs

Local signs include a palpable mass on rectal exam, asymmetric enlargement of one side of the perianal area, scooting, licking the perianal area, and difficulty defecating. Some tumors are large enough to be visible from the outside, but many are detected only on rectal exam. Dyschezia (painful defecation) and ribbon-like stools may indicate enlarged sublumbar lymph nodes compressing the rectum.

Systemic signs may relate to hypercalcemia (drinking and urinating more, vomiting, weakness, lethargy, decreased appetite) or to local tumor effects (constipation, tenesmus). Some dogs present with rear-leg weakness or stiffness from sublumbar lymph node enlargement compressing nerves. Any senior dog with persistent perianal symptoms, unexplained hypercalcemia, or progressive constipation deserves prompt veterinary evaluation including a rectal exam.

Diagnostic Workup

The workup begins with thorough history, physical exam including a detailed rectal exam, and routine bloodwork including a chemistry panel that captures calcium and phosphorus. Hypercalcemia is a major red flag and should always prompt a careful rectal exam. Urinalysis assesses kidney function, which can be affected by prolonged hypercalcemia. From there, imaging takes center stage. Abdominal ultrasound provides the best look at the primary tumor, sublumbar lymph nodes, and other abdominal organs. Three-view chest radiographs screen for pulmonary metastasis. Ionized calcium measurement is more reliable than total calcium for confirming true hypercalcemia.

Definitive diagnosis comes from cytology (fine-needle aspirate of the mass and any enlarged lymph nodes) and histopathology (after surgical removal). PTHrP testing can support the diagnosis when hypercalcemia is present, and parathyroid hormone (PTH) levels are typically suppressed in malignancy-associated hypercalcemia, which helps distinguish it from primary hyperparathyroidism. CT imaging is sometimes added for surgical planning, particularly when sublumbar lymph node involvement requires careful mapping. Ask your primary vet for a referral to a board-certified oncologist (ACVIM-Oncology) and surgeon (ACVS) once the diagnosis is suspected.

Treatment Options

Surgical removal of the primary tumor is the foundation of treatment. The procedure, called anal sacculectomy, removes the affected anal sac along with the tumor. When sublumbar lymph node metastasis is present, lymphadenectomy (removal of the affected nodes) may be performed as part of the same surgery or as a separate procedure. Surgery is technically demanding because of the proximity to the anal sphincter, so a board-certified surgeon is the best person to perform it. Complications can include fecal incontinence, wound dehiscence, and infection, all of which are typically managed successfully with appropriate post-operative care.

Radiation therapy is often added either before or after surgery to improve local control, particularly for larger tumors or when surgical margins are narrow. Chemotherapy is used in many cases, especially with advanced disease, with carboplatin and other agents being commonly chosen. The exact treatment plan is tailored to the dog’s stage, comorbidities, and the family’s goals.

Supportive care is essential when hypercalcemia is present. Intravenous fluids, sometimes diuretics, and bisphosphonates are tools to manage acute hypercalcemia while definitive treatment is planned. Pain control, anti-nausea medications, and appetite stimulants are commonly part of the picture. Brand-name NSAIDs are sometimes used as adjunctive therapy.

Prognosis and Quality of Life

Prognosis varies significantly by stage at diagnosis, presence of metastasis, and treatment chosen. Small tumors caught early without metastasis carry the best prognosis, with many dogs gaining meaningful additional time after multimodal treatment. Advanced cases with extensive lymph node metastasis or distant spread carry a more guarded prognosis. Hypercalcemia at diagnosis is generally a negative prognostic indicator. Specific survival numbers vary; your oncologist can give realistic expectations based on your specific dog’s stage and treatment plan.

Quality of life is the most important metric throughout treatment. A dog who is comfortable, defecating without pain, eating well, and engaging with the household is doing well. The ASPCA Pet Loss Hotline at 877-474-3310 is a resource for families navigating end-of-life decisions. Hospice and palliative care services are reasonable supplements to in-person veterinary care.

Living with an AGASACA Diagnosis

Day-to-day life after diagnosis often centers on managing comfort during defecation, monitoring calcium and kidney function, and supporting nutrition. Stool softeners may be recommended when sublumbar lymphadenopathy or local tumor effects are causing constipation; never use over-the-counter products without veterinary guidance because some are inappropriate for dogs with kidney compromise. Adequate hydration matters, especially when hypercalcemia is part of the picture, because well-hydrated kidneys handle calcium excretion better than dehydrated ones.

Recheck visits typically include rectal exams, abdominal ultrasound, chest radiographs, and bloodwork at intervals determined by your oncologist. Communicate any new urinary or defecation changes, lameness, or worsening appetite promptly. Many supportive interventions are easier when introduced early.

Cost, Adoption, and Senior Care

Treating AGASACA is expensive. Diagnostic imaging, biopsy, surgery (often by a specialist), radiation, chemotherapy, hospitalizations, and follow-up monitoring can total many thousands of dollars over the course of treatment. Specific dollar figures vary by region and complexity. Ask your vet about cost ranges in your area, and consider CareCredit, scratchpay, payment plans, and rescue-side aid funds. Pet insurance bought before symptoms appear is the strongest financial-protection tool. Our veterinary specialist cost breakdown walks through realistic ranges for these services.

For broader context, our cancer in dogs overview covers the most common canine cancer diagnoses. Senior dogs facing cancer are no less worth fighting for, and many treatment paths produce meaningful additional time. Browse our adopt-a-dog hub for senior dogs looking for soft landings.

Frequently Asked Questions

What is anal gland cancer in dogs called?

The most common form is apocrine gland adenocarcinoma of the anal sac, often abbreviated AGASACA. It arises from the glands within the anal sacs and is biologically aggressive with early metastasis to sublumbar lymph nodes.

What is paraneoplastic hypercalcemia?

Paraneoplastic hypercalcemia is high blood calcium caused by tumor-secreted parathyroid hormone-related protein. AGASACA is one of the most common canine cancers to cause it. Signs include increased drinking and urination, decreased appetite, vomiting, weakness, and kidney damage in severe cases.

How is anal gland cancer detected?

Many tumors are detected on routine rectal exam during wellness visits. Owners may notice scooting, licking the perianal area, asymmetric perianal enlargement, or difficulty defecating. Persistent hypercalcemia on bloodwork is another major red flag.

Can anal gland cancer in dogs be cured?

Small early tumors without metastasis can sometimes be cured with surgery alone. Most cases require multimodal treatment with surgery, possibly radiation, and chemotherapy. Even with comprehensive treatment, the goal is more often long-term control than absolute cure.

Is anal gland cancer painful?

It can be, particularly when defecation is affected by the tumor itself or by enlarged sublumbar lymph nodes compressing the rectum. Pain control is an important part of treatment at every stage. Quality-of-life conversations should happen early and often with your veterinary team.